Chinese Journal of Cancer Research

Papers
(The median citation count of Chinese Journal of Cancer Research is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Pathogenic germline variants in mismatch repair genes in patients with microsatellite instability-high gastric cancer114
Molecular features of gastroenteropancreatic neuroendocrine carcinoma: A comparative analysis with lung neuroendocrine carcinoma and digestive adenocarcinomas79
Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm clinical trial71
Transforming cancer cells for long-term living with cancer: An inspiring new approach53
Gastric cancer surgery in South Korea: Past, present, and future49
Efficacy of ctDNA methylation combined with traditional detection modality to detect liver cancer among high-risk patients: A multicenter diagnostic trial41
Focal ablation therapy presents promising results for selectively localized prostate cancer patients37
Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis36
Advancements in diagnosis and treatments of acute leukemia35
Gut microbiota and acute graft-versus-host disease30
Plasma cell-free DNA methylation markers for detection and prognosis of gastric cancer: A case-control study27
Detection and classification of breast lesions using multiple information on contrast-enhanced mammography by a multiprocess deep-learning system: A multicenter study23
Current trends and future directions of artificial intelligence in lung cancer diagnosis21
Updates of CSCO guidelines for colorectal cancer version 202521
Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors20
Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives19
Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A18
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancer18
Mn-based cGAS-STING activation for tumor therapy18
Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer18
Impact of resection margin status on survival in gastric cancer: A retrospective cohort study17
Is sentinel node navigation surgery feasible after non-curative endoscopic resection in patients with early gastric cancer?17
New roles of tumor-derived exosomes in tumor microenvironment17
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery: Final results of a phase II trial16
Optimal response population after neoadjuvant therapy for patients with locally advanced gastric cancer: A multicenter study16
Comparison of short- and long-term outcomes of robotic vs. laparoscopic gastrectomy for clinical serosa-invasive gastric cancer: A multicenter cohort study16
A multicenter study of a predictive model for pathological complete response after neoadjuvant therapy in breast cancer using multimodal digital biomarkers15
Clinicopathological significance and immunotherapeutic outcome of claudin 18.2 expression in advanced gastric cancer: A retrospective study14
Genomic characterization of peritoneal lavage cytology-positive gastric cancer14
Health economic evaluation on population-based Helicobacter pylori eradication and endoscopic screening for gastric cancer prevention14
Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study14
Breakthroughs in malignancy therapy: New advances and emerging trends in renal cell carcinoma14
Hypoxic tumor microenvironment: Destroyer of natural killer cell function14
Postoperative chemoradiotherapy with capecitabine and oxaliplatin vs. capecitabine for pathological stage N2 rectal cancer14
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS) mutant tumors13
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors13
Research progress of minimally invasive surgery for gastric cancer13
Long-term adherence to gastric cancer screening in South Korea: A 10-year follow-up study13
Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study12
Adjuvant therapy for hormone receptor-positive breast cancer: Perspective from a survey on breast cancer physicians’ acceptance of practice-changing data12
Lung cancer burden and trends from 2000 to 2018 in China: Comparison between China and the United State12
Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression11
Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies11
Advances, breakthroughs, and challenges in gastric cancer surgery11
SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis11
Preface to Special Issue: Breakthroughs in malignancy therapy: New advances and emerging trends—Awakening immune system: The new era of radioimmunotherapy10
High-risk extranodal natural killer/T-cell lymphoma patients could benefit more from allogeneic hematopoietic stem cell transplantation as consolidation: A real-world multicenter analysis in China10
Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers10
Clinicopathological and molecular features of HR+/HER2− breast cancer patients with distinct endocrine resistance patterns10
Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers10
Integrating AI-driven single-cell analysis to decode epithelial heterogeneity: A prognostic signature and translational immunotherapy strategy targeting KRT18-induced PD-L1 in lung adenocarcinoma9
Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer9
Epidemiology, early detection, and management of breast cancer in China: A comprehensive review9
Allogeneic hematopoietic cell transplantation in vulnerable populations: Advances and perspectives8
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in 8
Homoharringtonine combined with venetoclax and azacitidine: An effective and safe regimen for patients with refractory/relapsed acute myeloid leukemia8
Myeloid cells meet CD8+ T cell exhaustion in cancer: What, why and how8
Chromatin regulators TOP2A and PPARGC1A stratify prostate cancer risk and reveal TOP2A-driven progression via PI3K/AKT pathway8
Distal margin distance in radical resection of locally advanced rectal cancer after neoadjuvant therapy8
Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II s8
A multicenter study on the efficacy of dual-target neoadjuvant therapy for HER2-positive breast cancer and a consistent analysis of the efficacy evaluation of neoadjuvant therapy by Miller-Payne and R7
Integrated analysis of single-cell and bulk transcriptomes uncovers clinically relevant molecular subtypes in human prostate cancer7
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carci7
Development and validation of a clinical risk-prediction model for immune checkpoint inhibitor-related pneumonitis in patients with gastrointestinal cancer based on four machine learning algorithms7
CSCO guidelines for colorectal cancer version 2023: Updates and insights7
Breakthroughs of chimeric antigen receptor T-cell therapy in hematological malignancies: From ex vivo to in vivo7
Neoadjuvant chemotherapy with capecitabine combined with oxaliplatin for mid-low locally advanced rectal cancer with negative mesorectal fascia: Long-term outcomes of a prospective trial (PKUCH-R03 tr7
Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment7
Can one scoring system fit all? Comparative validation of CAR-HEMATOTOX, ALL-HEMATOTOX, and eIPM for predicting immune effector cell-associated hematotoxicity following CAR-T therapy in hematologic ma7
Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation7
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysis7
Manufacturing CAR-NK against tumors: Who is the ideal supplier?7
National validation of laparoscopic approach for locally advanced gastric cancer: Comparison of a randomized controlled trial and real-world practice results6
Pyrotinib is effective in both trastuzumab-sensitive and primary resistant HER2-positive breast tumors6
Evaluating diagnostic efficacy of multigene testing in non-diagnostic thyroid nodules by fine-needle aspiration cytology: A prospective cohort study6
Management guidelines for preventing exposure to antineoplastics6
Prognostic value of post-transplantation measurable residual disease in patients with myelodysplastic syndrome: A prospective cohort study6
Spatial transcriptome revealed associated biomarkers for endocrine therapy response in HR-positive/HER2-negative early breast cancer6
New insights into mechanisms and interventions of locoregional therapies for hepatocellular carcinoma6
Microbiota in colorectal cancer related to liver metastasis6
Artificial intelligence empowered biomaterials for cancer therapy: From rational design to clinical translation6
Reprogramming of fatty acid metabolism in thyroid cancer: Potential targets and mechanisms6
Updates of CSCO guidelines for diagnosis and treatment of lymphoma: 2026 edition6
MRD-directed and risk-adapted individualized stratified treatment of AML6
Gastric cancer in China: epidemiology, risk factors and screening5
Corrigendum to Efficacy and safety of low-dose cyclophosphamide combined with lenvatinib, pembrolizumab and TACE for unresectable hepatocellular carcinoma: A single-center, prospective, single-arm cli5
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesions5
Clinical impact of [68Ga]Ga-RM2 positron emission tomography imaging on staging and prognosis in estrogen receptor-positive breast cancer: A pilot study5
Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study5
A phase I study of Hemay022, an irreversible dual EGFR/HER2 tyrosine kinase inhibitor in Chinese patients with HER2-positive advanced breast cancer5
CT-based radiomics-deep learning model predicts occult lymph node metastasis in early-stage lung adenocarcinoma patients: A multicenter study5
Adaptive neoadjuvant endocrine therapy screens out prime population of ribociclib intensive adjuvant therapy5
A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer5
Managing evolution of metastatic prostate cancer: From hormone-sensitive to castration-resistant disease5
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road5
Epidemiology of pancreatic cancer: New version, new vision5
Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma5
IMpower210: A phase III study of second-line atezolizumab vs. docetaxel in East Asian patients with non-small cell lung cancer5
Gastric cancer surgery in the era of neoadjuvant immunotherapy5
Association of lifestyle factors with breast cancer incidence: An overview of systematic reviews4
Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remissio4
A comparative transcriptomic analysis at single-cell resolution reveals acral melanoma features distinct from cutaneous melanoma4
Context-dependent roles of 5-HT and its receptors in tumor growth and wound healing: Mechanisms and therapeutic implications4
Targeted activation of junctional adhesion molecule-like protein+ CD8+ T cells enhances immunotherapy in hepatocellular carcinoma4
Aqueous-soluble components of sporoderm-removed Ganoderma lucidum spore powder promote ferroptosis in oral squamous cell carcinoma4
Global, regional, and national burden of colorectal cancer, 1990−2021: An analysis from global burden of disease study 20214
Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma4
Artificial intelligence efficiently predicts gastric lesions, Helicobacter pylori infection and lymph node metastasis upon endoscopic images4
Exploring ideal operative time for best outcomes in gastric cancer surgery: A multi-institutional study based on KLASS-07 database3
Turmoil and breakthroughs: Highlights and growing pains in breast cancer therapy 2025−20263
Systematic functional interrogation of genome-wide association studies locus 17p13.3 deciphered role and genetic control of FAM57A in colorectal cancer development3
CARE framework: Rethinking randomized controlled trials for medical artificial intelligence3
Advances in gastric cancer treatment in 2024: Key advancements and emerging trends3
Comments on National guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)3
Challenge and future of cancer screening in China: Insights from esophageal cancer screening practice3
Integrated clinical-radiomic model for predicting treatment response of concurrent chemo-radiotherapy and radiotherapy alone in controversial subgroup of AJCC/UICC ninth edition stage I nasopharyngeal3
Revisiting nature of stage III non-small cell lung cancer: Anatomically defined, biologically systemic3
Updates of CSCO guidelines for colorectal cancer version 20263
Metabolic reprogramming signature predicts immunotherapy efficacy in lung adenocarcinoma: Targeting SLC25A1 to overcome immune resistance3
Cancer statistics in China: Epidemiology, risk factors, and prevention3
Preface to Special Issue: Cancer epidemiology, risk factors and screening3
Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine3
Novel germline JAK2 L808W and E305Vfs*4 mutations in familial essential thrombocythemia: Evidence from two pedigrees3
Leukemia epidemiology in China: Burden, trends and determinants in the 21st century3
0.63642907142639